{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0069-0501#drug","name":"XELJANZ XR","alternateName":"tofacitinib","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0069-0501"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA208246"},{"@type":"PropertyValue","propertyID":"UNII","value":"O1FF4DIV0D"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"cf74ba2f-afc5-4baa-8594-979c889a5831"}],"activeIngredient":"TOFACITINIB CITRATE","administrationRoute":["ORAL"],"dosageForm":"TABLET, FILM COATED, EXTENDED RELEASE","manufacturer":{"@type":"Organization","name":"Pfizer Laboratories Div Pfizer Inc"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA208246","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf74ba2f-afc5-4baa-8594-979c889a5831","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0501"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-31T08:10:19.710Z"}}